Search PDMR transactions

Notifier
Name
Magnus Hansson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Magnus Hansson
Position
Chief Medical Officer
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
NeuroVive Pharmaceutical AB
LEI
5493005YV22OTMUHZ183
Details of transaction
Type of financial instrument Name ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA NeuroVive Pharmaceutical BTA SE0014262408 Subscription 126,199 Quantity 0.80 SEK 29/04/2020 NASDAQ STOCKHOLM AB
Aggregation
Name ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
NeuroVive Pharmaceutical BTA SE0014262408 Subscription 29/04/2020 NASDAQ STOCKHOLM AB 126,199 (Quantity) 0.80 SEK
Total: 126,199
<< Back